Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk

Detalles Bibliográficos
Autores principales: Behr, Paulo Eduardo Ballvé, Moriguchi, Emilio Hideyuki, Castro, Iran, Bodanese, Luiz Carlos, Dutra, Oscar Pereira, Leães, Paulo Ernesto, Pimentel Filho, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cardiologia - SBC 2018
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078356/
https://www.ncbi.nlm.nih.gov/pubmed/30110052
http://dx.doi.org/10.5935/abc.20180133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078356/
https://www.ncbi.nlm.nih.gov/pubmed/30110052
http://dx.doi.org/10.5935/abc.20180133

Ejemplares similares